Orchid Pharma's newly-formed antimicrobial solutions division is targeting a turnover of up to Rs 300 crore in the next three ...

Focus has shifted from ‘ease’ to ‘speed’ of doing business in Andhra Pradesh, says IT Minister Lokesh. The government’s ...

HANSIZHUANG ® (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC – ...

India faces a rising concern as diabetes increasingly links to neurodegenerative diseases like dementia and Alzheimer’s. With ...

Hyderabad: In a recent BSE filing, Dr Reddy's Labs has informed that the United States Food & Drug Administration (USFDA) has ...

The Nifty Pharma has gained around 37% year to date. The growth continues to be led by the US sales and well supported by ...

US-based financial services company Vanguard Group acquired shares worth Rs 998 crore in seven Indian companies via open market transactions on the NSE. Concurrently, Zurich-based UBS Group AG sold ...

Indian equity markets witnessed a remarkable surge, with both the Sensex and Nifty reaching new record highs. This upward momentum was largely attributed to a rally in global markets following the U.S ...

Ginkgo Bioworks is pivoting: Once a synthetic biology darling, the flailing company has now turned to AI-driven protein ...

The domestic equity indices ended at a record high level on Friday, rising for the second day in a row. The Nifty closed above the 25,750 mark. Barring the Nifty PSU Bank index, all the other sectoral ...

LIC Mutual Fund has launched a new open-ended equity scheme focused on the manufacturing sector, aiming to benefit from India ...

Hyderabad: Laurus Labs Ltd. a research and development driven pharmaceutical and biotech company in India has announced the ...